argenx SE announced that at the Annual General Meeting of shareholders held on May 7, 2024 Dr. Brian L. Kotzin has been appointed as non-executive director to the Board of Directors for a term of four years. Dr. Kotzin brings broad medical and scientific research and development experience to the Board, supporting the Company?s innovation mission across therapeutic areas.
Market Closed -
Other stock markets
|
After market 01:05:08 pm | |||
349.3 EUR | +0.55% | 349.3 | 0.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.69% | 22.48B | |
+15.38% | 121B | |
+13.35% | 107B | |
-5.03% | 24.82B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.48% | 15.31B | |
+3.01% | 14.08B | |
+25.61% | 11.74B | |
+82.91% | 9.02B |
- Stock Market
- Equities
- ARGX Stock
- News argenx SE
- Argenx SE Appoints Dr. Brian L. Kotzin as Non-Executive Director to the Board of Directors